로딩 중...
52주 최고가 대비 38.3% 위치
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
SEC 13F 공시 기준 · 2026-Q1
SEC 13F 공시 기준 데이터입니다. 실제 현재 보유 현황과 다를 수 있으며, 투자 자문·권유·추천이 아닙니다.
| 재무 항목 | 2021년 | 2022년 | 2023년 | 2024년 | 2025년 |
|---|---|---|---|---|---|
| 주요 재무실적 (USD) | |||||
| 매출액 | - | $1.08B | $961.5M | $930.6M | $965.4M |
| 영업이익 | - | $334.2M | $170.9M | $108.3M | $45.1M |
| 당기순이익 | - | $-572.9M | $-91.7M | $-1.65B | $-284.3M |
| 잉여현금흐름 (FCF) | - | $282.6M | $62.9M | $-10.5M | $-12.3M |
| 수익성 비율 | |||||
| 영업이익률 | - | 31.0% | 17.8% | 11.6% | 4.7% |
| 순이익률 | - | -53.1% | -9.5% | -176.9% | -29.4% |
| ROE (자기자본이익률) | - | -32.0% | -5.4% | -1958.8% | 163.5% |
| ROA (자산이익률) | - | -7.8% | -1.3% | -32.0% | -5.8% |
| 성장성 비율 | |||||
| 매출 성장률 (YoY) | - | - | -10.9% | -3.2% | 3.7% |
| EPS 성장률 (YoY) | - | - | 84.2% | -1691.2% | 83.0% |
| 투자 지표 & 가치배수 | |||||
| PER (주가수익배수) | 25.2x | - | - | - | - |
| PBR (주가순자산배수) | - | 0.5x | 0.4x | 3.7x | - |
| PSR (주가매출배수) | - | 0.8x | 0.7x | 0.3x | 0.5x |
| FCF Yield | - | 31.4% | 9.1% | -3.4% | -2.7% |
| 재무 건전성 (안정성) | |||||
| 부채비율 (D/E) | - | 2.67 | 2.67 | 54.05 | -26.54 |
| 유동비율 | - | 2.54 | 1.16 | 0.82 | 0.86 |
MOLINA HEALTHCARE INC
$179.86
$9.4B